Clostridium difficile infection in children: A review

Journal of Pediatric Gastroenterology and Nutrition

Volumn 63, Issue 6, 2016, Pages e130-e140

  Borali, Elena ^a   De Giacomo, Costantino ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Clostridium difficile; Colitis; Community associated disease; Infectious diarrhoea; Paediatrics

Indexed keywords

ANTIBIOTIC AGENT; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

AGE; ANTIBIOTIC THERAPY; CHILD; CHILD HOSPITALIZATION; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; HOST; HUMAN; IMMUNITY; MICROBIAL COLONIZATION; MIXED INFECTION; MULTICENTER STUDY (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; RISK FACTOR; STOMACH ACID; SYSTEMATIC REVIEW (TOPIC); CLOSTRIDIUM INFECTION; DIARRHEA; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMORBIDITY; DIARRHEA; HUMANS; INCIDENCE; INFANT; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84967333667     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001264     Document Type: Review

References (98)

1. Hall IC, O'Toole E. Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 1935;49:390-402.
2. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009;7:526-36.
3. Dubberke ER, Gerding DN, Classen D, et al. Strategies to prevent Clostridium difficile infection in acute care hospital. Infect Control Hosp Epidemiol 2008;29:S81-9.
4. Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol 2011;8:17-26.
5. Hourigan SK, Oliva-Hemker M. The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease. Dig Dis Sci 2014;59:2222-7.
6. Bartlett JG. Narrative review: The new epidemic of Clostridium difficileassociated enteric disease. Ann Intern Med 2006;145:758-64.
7. Sammons JS, Toltzis P. Recent trends in the epidemiology and treatment of C. difficile infection in children. Curr Opin Pediatr 2013;25:116-21.
8. Crobach MJT, Dekkers OM, Wilcox MH, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009;15:1053-66.
9. Loo VG. Environmental interventions to control Clostridium difficile. Infect Dis Clin North Am 2015;29:83-91.
10. Centers for Disease Control and Prevention (CDC). Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 2012;61:157-62.
11. Loo VG, Poirier L, Miller M, et al. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-9.
12. Morinville V, McDonalds J. Clostridium difficile-associated diarrhea in 200 Canadian children. Can J Gastroenterol 2005;19:497-501.
13. Schutze GE, Willoughby RE. Committee on Infectious Disease, American Academy of Pediatrics. Clostridium difficile infection in infants and children. Pediatrics 2013;131:196-200.
14. Borali E, Ortisi G, Moretti C, et al. Community-acquired Clostridium difficile infection in children: A retrospective study. Dig Liver Dis 2015;47:842-6.
15. Tschudin-Sutter S, Tamma PD, Milstone AM, et al. Predictors of first recurrence of Clostridium difficile infections in children. Pediatr Infect Dis J 2014;33:414-6.
16. Wendt JM, Cohen JA, Mu Y, et al. Clostridium difficile infection among children across diverse US geographic locations. Pediatrics 2014;133:651-8.
17. Cohen SH, Gerding DN, Johnson S, et al. Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-55.
18. Zilberberg MD, Shorr AF, Kollef MH. Increased in Clostridium difficile-related hospitalizations among infants in the Unites States, 2000-2005. Pediatr Infect Dis J 2008;27:1111-3.
19. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28:140-5.
20. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficile related mortality rates, United States, 1999-2004. Emerg Infect Dis 2007;13:1417-9.
21. Nylund CM, Goudie A, Garza JM, et al. Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med 2011;165:451-7.
22. Kim J, Smathers SA, Prasad P, et al. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008;122:1266-70.
23. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children United States, 1997-2006. Emerg Infect Dis 2010;16:604-9.
24. Khalaf N, Crews JD, DuPont HL, et al. Clostridium difficile: an emerging pathogen in children. Discov Med 2012;14:105-13.
25. Pant C, Deshpande A, Gilroy R, et al. Rising incidence of Clostridium difficile related discharges among hospitalized children in the United States. Infect Control Hosp Epidemiol 2015;37:104-6.
26. Centers for Disease Control and Prevention. Surveillance for community associated Clostridium difficile-Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008;57:340-3.
27. Sandora TJ, Fung M, Flaherty K, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J 2011;30:580-4.
28. Benson L, Song X, Campos J, et al. Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol 2007;28:1233-5.
29. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079-84.
30. Toltzis P, Kim J, Dul M, et al. Presence of the epidemic North American Pulsed Field type 1 Clostridium difficile strain in hospitalized children. J Pediatr 2009;154:607-8.
31. Spigaglia P, Barbanti F, Castagnola E, et al. Clostridium difficile infection (CDI) in children due to hypervirulent strains PCR-ribotype 027: an emblematic report of two cases. Anaerobe 2015;36:91-3.
32. Bauer MP, Notermans DW, van Benthem BH, et al. Clostridium difficile infection in Europe: A hospital-based survey. Lancet 2011;377:63-73.
33. Hensgens MP, Goorhuis A, Notermans DW, et al. Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill 2009;14:1-3.
34. Wilcox MH, Shetty N, Fawley WN, et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping based surveillance scheme in England. Clin Infect Dis 2012;55:1056-63.
35. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001;292:1115-8.
36. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635-8.
37. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011;121:2126-32.
38. Palmer C, Bik EM, DiGiulio DB, et al. Development of the human infant intestinal microbiota. PLoS Biol 2007;5:e177.
39. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008;197:435-8.
40. Jangi S, Lamont JT. Asympomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterolog Nutr 2010;51:2-7.
41. Matsuki S, Ozaki E, Shozu M, et al. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. Int Microbiol 2005;8:43-8.
42. Penders J, Vink C, Driessen C, et al. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett 2005;243:141-7.
43. Delmée M, Verellen G, Avesani V, et al. Clostridium difficile in neonates: serogrouping and epidemiology. Eur J Pediatr 1988;147:36-40.
44. Monot M, Eckert C, Lemire A, et al. Clostridium difficile: new Insights into the evolution of the pathogenicity locus. Sci Rep 2015;5:15023.
45. Govind R, Dupuy B. Secretion of Clostridium difficile toxins A and B requires the holin-like protein TcdE. PLoS Pathog 2012;8:e1002727.
46. Matamouros S, England P, Dupuy B. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol 2007;64:1274-88.
47. Carter GP, Lyras D, Allen DL, et al. Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J Bacteriol 2007;189:7290-301.
48. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med 2008;359:1932-40.
49. Cairns MD, Stabler RA, Shetty N, et al. The continually evolving Clostridium difficile species. Future Microbiol 2012;7:945-57.
50. Pothoulakis C, Lamont JT. Microbes and microbial toxins: paradigms for microbial-mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins. Am J Physiol Gastrointest Liver Physiol 2001;280:G178-83.
51. Viscidi R, Laughon BE, Yolken R, et al. Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis 1983;148:93-100.
52. Bryant K, McDonald LC. Clostridium difficile infections in children. Pediatr Infect Dis J 2009;28:145-6.
53. Kim J, Shaklee JF, Smathers S, et al. Risk factors and outcomes associated with severe Clostridium difficile infection in children. Pediatr Infect Dis J 2012;31:134-8.
54. Samady W, Pong A, Fisher E. Risk factors for the development of Clostridium difficile infection in hospitalized children. Curr Opin Pediatr 2014;26:568-72.
55. Duleba K, Pawlowska M, Wietlicka-Piszcz M. Clostridium difficile infection in children hospitalized due to diarrhea. Eur J Clin Microbiol Infect Dis 2014;33:201-9.
56. Schwartz KL, Darwish I, Richardson SE, et al. Severe clinical outcome is uncommon in Clostridium difficile infection in children: A retrospective cohort study. BMC Pediatr 2014;14:28.
57. Samady W, Bush R, Pong A, et al. Predictors of Clostridium difficile infections in hospitalized children. J Hosp Med 2014;9:94-8.
58. Owens RC Jr, Donskey CJ, Gaynes RP, et al. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008;46(suppl 1):S19-31.
59. Janarthanan S, Ditah I, Adler DG, et al. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: A meta-analysis. Am J Gastroenterol 2012;107:1001-10.
60. Kwok CS, Arthur AK, Anibueze CI, et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-Analysis. Am J Gastroenterol 2012;107:1011-9.
61. Jimenez J, Drees M, Loveridge-Lenza B, et al. Exposure to gastric acid-suppression therapy is associated with healthcare-associated and community-associated C. difficile infection in children. J Pediatr Gastroenterol Nutr 2015;61:208-11.
62. Hassell E. Over-prescription of acid-suppressing medications in infants: how it came about, why it's wrong, and what to do about it. J Pediatr 2012;160:193-8.
63. Mc Laughlin D, Friedmacher F, Puri P. The impact of Clostridium difficile on paediatric surgical practice: A systematic review. Pediatr Surg Int 2014;30:853-9.
64. Martinelli M, Strisciuglio C, Veres G, et al. Clostridium difficile and pediatric inflammatory bowel disease: A prospective, comparative, multicenter, ESPGHAN study. Inflamm Bowel Dis 2014;20:2219-25.
65. De Graaf H, Pai S, Burns DA, et al. Co-infection as a confounder for the role of Clostridium difficile infection in children with diarrhea: A summary of the literature. Eur J Clin Microbiol Infect Dis 2015;34:1281-7.
66. Elliott B, Chang BJ, Golledge CL, et al. Clostridium difficile-associated diarrhea. Intern Med J 2007;37:561-8.
67. Gogate A, De A, Nanivandekar R, et al. Diagnostic role of stool culture & toxin detection in antibiotic associated diarrhea due to Clostridium difficile in children. Indian J Med Res 2005;122:518-24.
68. Pai S, Aliyu SH, Enoch DA, et al. Five years' experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management. PLoS One 2012;7:e51728.
69. Nicholson MR, Thomsen IP, Slaughter JC, et al. Novel risk factors for recurrent Clostridium difficile infection in children. J Pediatr Gastroenterol Nutr 2015;60:18-22.
70. Khanna S, Baddour LM, Huskins WC, et al. The epidemiology of Clostridium difficile infection in children: A population-based study. Clin Infect Dis 2013;56:1401-6.
71. Kociolek LK, Palac HL, Patel SJ, et al. Risk factors for recurrent Clostridium difficile infection in children: A nested case-control study. J Pediatr 2015;167:384-9.
72. Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013;108:478-98.
73. Planche T, Aghaizu A, Holliman R, et al. Diagnosis of Clostridium difficile infection by toxin detection kits: A systematic review. Lancet Infect Dis 2008;8:777-84.
74. Fenner L, Widmer AF, Goy G, et al. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 2008;46:328-30.
75. Peterson LR, Manson RU, Paule SM, et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis 2007;45:1152-60.
76. Luna RA, Boyanton BL, Mehta S, et al. Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital. J Clin Microbiol 2011;49:851-7.
77. Department of Health (2012). Updated guidance on the diagnosis and reporting of Clostridium difficile. Available from: https://www.gov. uk/government/uploads/system/uploads/attachment-data/file/215135/dh-133016.pdf. Accessed September 1, 2015.
78. Pickering L, Baker C, Bernstein H, et al. Clostridium difficile. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012:285-7.
79. Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficileassociated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45:302-7.
80. Vardakas KZ, Polyzos KA, Patouni K, et al. Treatment failure and recurrence of Clostridium difficile infections following treatment with vancomycin or metronidazole: A systematic review of the evidence. Int J Antimicrob Agents 2012;40:1-8.
81. Vaishnavi C. Fidaxomicin-the new drug for Clostridium difficile infection. Indian J Med Res 141 2015;141:398-407.
82. Smeltzer S, Hassoun A. Successful use of fidaxomicin in recurrent Clostridium difficile infection in a child. J Antimicrob Chemother 2013;68:1688-9.
83. Ooi CY, Dilley AV, Day AS. Saccharomyces boulardii in a child with recurrent Clostridium difficile. Pediatr Int 2009;51:156-8.
84. Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol 2013;29:79-84.
85. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011;53:994-1002.
86. Russell G, Kaplan J, Ferraro M, et al. Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: A proposed treatment protocol. Pediatrics 2010;126:e239-42.
87. Kronman MP, Nielson HJ, Adler AL, et al. Fecal microbiota transplantation via nasogastric tube for recurrent Clostridium difficile infection in pediatric patients. J Pediatr Gastroenterol Nutr 2015;60:23-6.
88. Kahn SA, Young S, Rubin DT. Colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection in a child. Am J Gastroenterol 2012;107:1930-1.
89. Russell G, Kaplan JL, Youngster I, et al. Fecal transplant for recurrent Clostridium difficile infection in children with and without inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014;58:588-92.
90. Pierog A, Mencin A, Reilly NR. Fecal microbiota transplantation in children with recurrent Clostridium difficile infection. Pediatr Infect Dis J 2014;33:1198-200.
91. Zipursky JS, Sidorsky TI, Freedman CA, et al. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis 2012;55:1652-8.
92. Lowy I, Molrine DC, Leav BA, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010;362:197-205.
93. Foglia G, Shah S, Luxemburger C, et al. Clostridium difficile: development of a novel candidate vaccine. Vaccine 2012;30:4307-9.
94. Huang JH, Wu CW, Lien SP, et al. Recombinant lipoprotein-based vaccine candidates against C. difficile infections. J Biomed Sci 2015;22:65.
95. Pant C, Deshpande A, Altaf MA, et al. Clostridium difficile infection in children: A comprehensive review. Curr Med Res Opin 2013;29:967-84.
96. McGlone SM, Bailey RR, Zimmer SM, et al. The economic burden of Clostridium difficile. Clin Microbiol Infect 2012;18:282-9.
97. Muto CA, Blank MK, Marsh JW, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis 2007;45:1266-73.
98. Leffler DA, Lamont JT. Clostridium difficile Infection. N Engl J Med 2015;373:287-8.